http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019000612-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5cff08c83f8a0a676627b61ed027f2ef
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-1682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-16901
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-1635
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-16
filingDate 2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc65e12de1d73c5a296b63874392feca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ee120ffbab1ea31eaf2cd23e2b14594
publicationDate 2019-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2019000612-A1
titleOfInvention Accommodating intraocular lens
abstract An accommodating intraocular lens (IOL) device adapted for implantation in the lens capsule of a subject's eye. The IOL device includes an anterior refractive optical element and a membrane coupled to the refractive optical element. The anterior refractive optical element and the membrane define an enclosed cavity configured to contain a fluid. At least a portion of the membrane is configured to contact a posterior area of the lens capsule adjoining the vitreous body of the subject's eye. The fluid contained in the enclosed cavity exerts a deforming or displacing force on the anterior refractive optical element in response to an anterior force exerted on the membrane by the vitreous body. The IOL device may further include a haptic system to position the anterior refractive optical element and also to engage the zonules and ciliary muscles to provide additional means for accommodation.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-112020003939-T5
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10512535-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11076948-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021092222-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11065107-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406490-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406491-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021034187-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10898316-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11464622-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10898317-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NL-2027301-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10485654-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11464621-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11045309-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10842616-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020197386-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NL-2028038-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446138-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10526353-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10647831-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020231260-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11000364-B2
priorityDate 2010-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009264998-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011224788-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945

Total number of triples: 45.